Iridex Corp Asset Turnover Ratio (IRIX), as of second quarter 2026, current and historic results, rankings and more - CSIMarket
CSIMarket
 


Iridex Corp  (NASDAQ: IRIX)
 

Iridex Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Iridex Corp asset turnover ratio, the ability of Iridex Corp's assets to generate revenue in the second quarter 2026, increased sequentially to 1.81 in the second quarter (Jul 04 2026), IRIX's balance sheet remain strong.

Within sector 7 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the Second Quarter 2026 compared to the preceding quarter from 248 to 272.

Asset Turnover Ratio Definition



IRIX Asset Turnover Ratio (Jul 04 2026)
II. Quarter
(Apr 04 2026)
I. Quarter
(Jan 03 2026)
IV. Quarter
(Sep 27 2025)
III. Quarter
(Jun 28 2025)
II. Quarter
Y / Y Asset Change -13.7 % -17.41 % 0.05 % -5.8 % 3.03 %
Y / Y Revenue Change -0.91 % 6.21 % 8.38 % 6.09 % 4.51 %
Asset Turnover Ratio (TTM) 1.81 1.75 1.64 1.6 1.56
IRIX's Total Ranking # 272 # 248 # 299 # 1708 # 337
Seq. Asset Change -3.59 % -3.01 % 3.67 % -10.98 % -7.74 %
Seq. Revenue Change 7.03 % -20.26 % 22.57 % -5.28 % 14.72 %



Asset Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 8
Healthcare Sector # 24
Overall Market # 272

Asset Turnover Ratio Statistics
High Average Low
1.74 1.23 0.93
(Jul 04 2026)   (Jul 01 2017)







Companies with similar Asset Turnover Ratio for the quarter ending Jul 04 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Jul 04 2026 Assets at quarter ending Jul 04 2026
Earth Science Tech Inc   3.95 $ 34.647  Millions$ 8.769  Millions
Lifevantage Corp  2.81 $ 180.947  Millions$ 64.444  Millions
P3 Health Partners Inc   2.25 $ 1,502.838  Millions$ 667.189  Millions
Vycor Medical Inc   2.10 $ 1.807  Millions$ 0.860  Millions
Biofrontera Inc   1.98 $ 45.956  Millions$ 23.207  Millions
Iridex Corp  1.81 $ 51.044  Millions$ 28.259  Millions
Progyny Inc   1.78 $ 1,311.298  Millions$ 737.959  Millions
Chemed Corporation  1.65 $ 2,595.001  Millions$ 1,569.302  Millions
Aspira Women s Health inc   1.62 $ 9.029  Millions$ 5.569  Millions
Adm Tronics Unlimited Inc   1.59 $ 3.240  Millions$ 2.034  Millions
Lftd Partners Inc   1.56 $ 35.335  Millions$ 22.674  Millions
Nephros Inc   1.54 $ 21.686  Millions$ 14.113  Millions
Medinotec Inc   1.52 $ 10.247  Millions$ 6.745  Millions
Evofem Biosciences Inc   1.47 $ 18.045  Millions$ 12.261  Millions
Infusystem Holdings Inc  1.45 $ 143.335  Millions$ 98.950  Millions
Medpace Holdings Inc   1.41 $ 2,782.288  Millions$ 1,978.819  Millions
Edap Tms Sa  1.37 $ 111.051  Millions$ 81.022  Millions
Idexx Laboratories Inc  1.34 $ 4,553.792  Millions$ 3,391.326  Millions
Vaxart Inc   1.31 $ 243.064  Millions$ 185.077  Millions
Tactile Systems Technology Inc   1.29 $ 350.319  Millions$ 271.226  Millions
Lifeloc Technologies Inc   1.29 $ 9.269  Millions$ 7.201  Millions
Precipio inc   1.29 $ 27.198  Millions$ 21.149  Millions
Interpace Biosciences Inc   1.28 $ 36.519  Millions$ 28.458  Millions
Exagen Inc   1.27 $ 71.427  Millions$ 56.184  Millions
Electromed Inc   1.24 $ 72.076  Millions$ 58.289  Millions
Rockwell Medical inc   1.22 $ 69.827  Millions$ 57.145  Millions
Ardent Health Inc   1.22 $ 6,405.940  Millions$ 5,244.371  Millions
Docgo Inc   1.22 $ 294.721  Millions$ 241.732  Millions
Henry Schein Inc   1.21 $ 13,602.000  Millions$ 11,249.250  Millions
Inogen Inc   1.20 $ 354.304  Millions$ 294.283  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.